...
首页> 外文期刊>Biochemical and Biophysical Research Communications >Endothelial microparticles-mediated transfer of microRNA-19b promotes atherosclerosis via activating perivascular adipose tissue inflammation in apoE ?/? mice
【24h】

Endothelial microparticles-mediated transfer of microRNA-19b promotes atherosclerosis via activating perivascular adipose tissue inflammation in apoE ?/? mice

机译:内皮微粒介导的microRNA-19B的转移通过激活血管血管脂肪组织炎症在Apoe中促进动脉粥样硬化?/? 老鼠

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Microparticles(MPs) are the major carriers of circulating microRNAs. Our previous study has shown that microRNA (miR)-19b in endothelial cell-derived microparticles (EMPs) is significantly increased in patients with unstable angina. However, little is known about the relationship between miR-19b in EMPs and the progression of atherosclerosis. The aim of the present study was to define the role and potential mechanism of miR-19b incorporated in EMPs in the development of atherosclerosis. Western-diet-fed apoE ?/? mice were injected with phosphate buffered solution(PBS), EMP carrying microRNA control(EMP control ) or miR-19b mimic (EMP miR19b ) intravenously. Systemic treatment with EMP miR19b significantly accelerated carotid artery atherosclerosis progression by increasing lipid, macrophages and smooth muscle cells and decreasing collagen content in atherosclerotic plaque. Fluorescence-labelled EMP miR19b injection proved that miR-19b could be transported into perivascular adipose tissue(PVAT) by EMPs. EMP miR19b treatment also promoted inflammatory cytokines secretion and macrophages infiltration in PVAT. In further experiment, apoE ?/? mice were divided into 3 groups: EMP control PVAT(+), EMP miR19b PVAT(+) and EMP miR19b PVAT(-), based on removing or keeping pericarotid adipose tissue and injected with EMP control or EMP miR19b . Loss of PVAT attenuated EMP miR19b -mediated effects on increasing carotid atherosclerosis formation and inflammatory cytokines level in plaque. EMP miR19b inhibited suppressor of cytokine signaling 3 (SOCS3) expression in PVAT. Our findings demonstrate that miR-19b in EMPs exaggerates atherosclerosis progression by augmenting PVAT-specific inflammation proceeded by downregulating SOCS3 expression. Highlights ? EMP miR19b promotes atherosclerosis progression. ? EMP miR19b increases inflammation in perivascular adipose tissue. ? EMP can transfer microRNA-19b into perivascular adipose tissue. ? SOCS3 is a direct target of microRNA-19b.
机译:摘要微粒(MPS)是循环MicroRNA的主要载体。我们以前的研究表明,在不稳定的心绞痛患者中,内皮细胞衍生的微粒(EMPS)中的MicroRNA(miR)-19b显着增加。然而,关于EMPS中miR-19b之间的关系和动脉粥样硬化的进展几乎是知之甚少。本研究的目的是定义EMPS在动脉粥样硬化发展中掺入EMPS中的miR-19b的作用和潜在机制。西食饮食喂养的apoe?/?将小鼠用磷酸盐缓冲溶液(PBS),EMP载体静脉注射MICRRNA对照(EMP控制)或MIR-19B模拟(EMP MIR19B)。通过增加脂质,巨噬细胞和平滑肌细胞和在动脉粥样硬化斑块中降低胶原蛋白含量,通过增加eMP miR19b的全身治疗显着加速颈动脉动脉粥样硬化进展。荧光标记的EMP MIR19B注射证明,MIR-19B可以通过EMPS传送到大脑脂肪组织(PVAT)中。 EMP MiR19B治疗还促进了PVAT中的炎症细胞因子分泌物和巨噬细胞浸润。在进一步的实验中,Apoe?/?将小鼠分为3组:EMP控制PVAT(+),EMP MIR19B PVAT(+)和EMP MIR19B PVAT( - ),基于除去或保持果皮脂肪组织并注射EMP控制或EMP MIR19B。 PVAT损失衰减EMP MIR19B励部对牙龈动脉粥样硬化形成和炎症细胞因子水平增加的影响。 EMP MIR19B抑制PVAT中细胞因子信号3(SOCS3)表达的抑制抑制剂。我们的研究结果表明,EMPS中的miR-19b通过增强SOCS3表达的增强PVAT特异性炎症来夸大动脉粥样硬化进展。强调 ? EMP MIR19B促进动脉粥样硬化进展。还EMP MIR19B增加血管外脂肪组织中的炎症。还EMP可以将MicroRNA-19B转移到大脑血管脂肪组织中。还SOCS3是MicroRNA-19B的直接目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号